A5047855689- Cardiac tumors and thrombi
- Lung Cancer Diagnosis and Treatment
- Trauma Management and Diagnosis
- Medical Imaging and Pathology Studies
- Pleural and Pulmonary Diseases
- Pulmonary Hypertension Research and Treatments
- Tracheal and airway disorders
- Congenital Diaphragmatic Hernia Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Pneumothorax, Barotrauma, Emphysema
- Soft tissue tumor case studies
- Congenital Heart Disease Studies
- Venous Thromboembolism Diagnosis and Management
- Sarcoidosis and Beryllium Toxicity Research
- Sarcoma Diagnosis and Treatment
- Bone Tumor Diagnosis and Treatments
- COVID-19 and healthcare impacts
- IgG4-Related and Inflammatory Diseases
- Ultrasound in Clinical Applications
- Vascular Anomalies and Treatments
- Case Reports on Hematomas
- Gastrointestinal disorders and treatments
- Eosinophilic Disorders and Syndromes
Hospital Universitario Ramón y Cajal
2016-2025
Instituto Cajal
2014-2023
Catholic University of Ávila
2021
Hospital La Paloma
2017-2018
University Radiology
2018
Yahoo (United Kingdom)
2012
MD Anderson Cancer Center Madrid
2008
Instituto Tecnológico PET
2008
Hospital Universitario La Paz
2000-2005
Universidad Autónoma de Madrid
2001
PURPOSE: To retrospectively review clinical, pathologic, and imaging features of angiosarcoma the spleen in 12 patients. MATERIALS AND METHODS: Institutional board approval was obtained, informed consent not required. Records cases proved were accessed from files Armed Forces Institute Pathology. Clinical, findings reviewed. Presenting signs symptoms recorded, pathologist confirmed diagnosis determined gross microscopic morphologic each spleen. Radiologists reviewed available images to...
Canakinumab is a human IgGκ monoclonal antibody, with high affinity and specificity for IL-1β. The Anti-Inflammatory Thrombosis Outcome Study (CANTOS) trial, evaluating canakinumab cardiovascular disease, provided the first signal of potential IL-1β inhibition on lung cancer incidence reduction. Here, we describe rationale design CANOPY-N, randomized Phase II trial or without immune checkpoint as neoadjuvant treatment in patients non-small-cell cancer. Patients stage IB to IIIA eligible...
Sarcomatoid carcinoma is a subtype of non-small cell lung cancer (NSCLC) characterized by mesenchymal – epithelial transition component and awful prognosis. In this report, based on case stage IV sarcomatoid with an extraordinary evolution survival over 4 years, we address unresolved questions about the treatment cancer. We also make literature review key factors that characterize histology should be considered when treating those patients. presents mutations as KRAS, EGFR, ALK or MET in up...
Since the outbreak of coronavirus disease 2019 (COVID-19) pandemic, healthcare systems have focused their efforts into finding a treatment to avoid fatal outcomes severe acute respiratory syndrome due coronavirus‑2 (SARS-CoV-2). Benefits and risks systemic treatments remain unclear, with multiple clinical trials still ongoing. Radiotherapy could play role in reducing inflammatory response lungs relieve life-threatening symptoms.We designed prospective study Ultra-Low Doses Therapy Radiation...
Abstract Introduction:Since the outbreak of COVID-19 pandemic, healthcare system has focused its effort to find a treatment avoid fatal outcome severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Benefits and risks systemic treatments are unclear. Radiotherapy could play role in reducing inflammatory response lungs relieve life-threatening symptomsMethods:We designed prospective study Ultra-Low-Doses Therapy with Radiation Applied (ULTRA-COVID) for patients that no candidates...